1887

Chapter 34 : Pathogenesis of Theiler's Murine Encephalomyelitis Virus-Induced Disease

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Pathogenesis of Theiler's Murine Encephalomyelitis Virus-Induced Disease, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817916/9781555812102_Chap34-1.gif /docserver/preview/fulltext/10.1128/9781555817916/9781555812102_Chap34-2.gif

Abstract:

Strains of Theiler’s murine encephalomyelitis virus (TMEV) were first isolated by Max Theiler at the Rockefeller Foundation during his investigations of yellow fever virus vaccine. The GDVII strain of TMEV was named because this isolate was the seventh made by George, Theiler’s technician, from an uninoculated mouse that was found to be diseased (paralyzed). The presence of polypyrimidine tract binding protein (PTB) and nPTB binding sites in GDVII affects neurovirulence. The importance of sialic acid binding to virus entry is further supported by studies that showed that a variant of DA that has enhanced binding to L929 cells and has mutations in the VP2 puff B or VP1 loop 2; this region is also one that has been found important in disease pathogenesis. It was found that demyelination can occur when one replaces any part of the DA genome with the corresponding segment from the GDVII genome. In addition, the immune system is believed to mediate the pathology in both diseases. Therefore, it is hoped that investigations of TMEV-induced demyelination may provide insights into the pathogenesis of multiple sclerosis. The identity of the TMEV receptor, or what are probably TMEV receptors, is likely to help clarify the pathogenesis of TMEV-induced central nervous system disease. In addition, the identification of cell-specific RNA-binding proteins that affect translation and regulate the synthesis of L* versus the polyprotein is also likely to help in the understanding of picornaviral gene expression and TMEV disease pathogenesis.

Citation: Roos R. 2002. Pathogenesis of Theiler's Murine Encephalomyelitis Virus-Induced Disease, p 427-435. In Semler B, Wimmer E (ed), Molecular Biology of Picornavirus. ASM Press, Washington, DC. doi: 10.1128/9781555817916.ch34

Key Concept Ranking

Central Nervous System Diseases
0.45434442
Theiler's Murine Encephalomyelitis
0.41964507
0.45434442
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

The TMEV single-stranded RNA of approximately 8,100 nucleotides. The 5′ UTR precedes the polyprotein coding region, which has the leader (L) coding region as its most amino terminus; a 3′ UTR is at the 3′ end of the genome. The genomic region of P1 is divided into 1A, 1B, 1С, and 1D coding regions, which synthesize, respectively, the structural proteins VP4, VP2, VP3, and VP1. P2 (which includes 2A, 2B, 2C, and 2D) and P3 (which includes 3А, 3B, 3C, and 3D) encode various nonstructural proteins. The polyprotein's initiation codon is at nucleotide 1066, while the initiation codon for L* in the case of the DA strain of TMEV is at nucleotide 1079. There is a stop codon (UAG) for L* at nucleotide 1547. The GDVII strain of TMEV has an ACG rather than an AUG in the position corresponding to the DA L* initiation codon, so GDVII fails to synthesize L*.

Citation: Roos R. 2002. Pathogenesis of Theiler's Murine Encephalomyelitis Virus-Induced Disease, p 427-435. In Semler B, Wimmer E (ed), Molecular Biology of Picornavirus. ASM Press, Washington, DC. doi: 10.1128/9781555817916.ch34
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817916.chap34
1. Aubagnac, S.,, M. Brahic,, and J. F. Bureau. 1999. Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J. Virol. 73: 7965 7971.
2. Badshah, C.,, M. A. Calenoff,, and K. Rundell. 2000. The leader polypeptide of Theiler's murine encephalomyelitis virus is required for the assembly of virions in mouse L cells. J. Virol. 74: 875 882.
3. Bandyopadhyay, P. K.,, C. Wang,, and H. L. Lipton. 1992. Cap-independent translation by the 5′ untranslated region of Theiler's murine encephalomyelitis virus. J. Virol. 66: 6249 6256.
4. Begolka, W. S.,, C. L. Vanderlugt,, S. M. Rahbe,, and S. D. Miller. 1998. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 161: 4437 4446.
5. Borson, N. D.,, C. Paul,, X. Lin,, W. K. Nevala,, M. A. Strausbauch,, M. Rodriguez,, and P. J. Wettstein. 1997. Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 71: 5244 5250.
6. Brahic, M.,, W. G. Stroop,, and J. R. Baringer. 1981. Theiler's virus persists in glial cells during demyelinating disease. Cell 26: 123 128.
7. Calenoff, M. A.,, C. S. Badshah,, M.C. Dal Canto,, H. L. Lipton,, and M. K. Rundell. 1995. The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells. J. Virol. 69: 5544 5549.
8. Chen, H. H.,, W. P. Kong,, and R. P. Roos. 1995. The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J. Virol. 69: 8076 8078.
9. Chen, H. H.,, W. P. Kong,, L. Zhang,, P. L. Ward,, and R. P. Roos. 1995. A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat. Med. 1: 927 931.
10. Daniels, J. B.,, A. M. Pappenheimer,, and S. Richardson. 1952. Observation on encephalomyelitis of mice (DA strain). J. Exp. Med. 96: 517 535.
11. Dethlefs, S.,, M. Brahic,, and E. L. Larsson-Sciard. 1997. An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence. J. Virol. 71: 8875 8878.
12. Friedmann, A.,, and H. Lipton. 1980. Replication of Theiler's murine encephalomyelitis viruses in BHK21 cells: an electron microscopic study. Virology 101: 389 398.
13. Fu, J.,, M. Rodriguez,, and R. P. Roos. 1990. Strains from both Theiler's virus subgroups encode a determinant for demyelination. J. Virol. 64: 6345 6348.
14. Fu, J. L.,, S. Stein,, L. Rosenstein,, T. Bodwell,, M. Routbort,, B. L. Semler,, and R. P. Roos. 1990. Neurovirulence determinants of genetically engineered Theiler viruses. Proc. Natl. Acad. Sci. USA 87: 4125 4129.
15. Fujinami, R. S.,, A. Rosenthal,, P. W. Lampert,, A. Zurbriggen,, and M. Yamada. 1989. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J. Virol. 63: 2081 2087.
16. Ghadge, G. D.,, L. Ma,, S. Sato,, J. Kim,, and R. P. Roos. 1998. A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J. Virol. 72: 8605 8612.
17. Gingras, A. C.,, Y. Svitkin,, G. J. Belsham,, A. Pause,, and N. Sonenberg. 1996. Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus. Proc. Natl. Acad. Sci. USA 93: 5578 5583.
18. Grant, R. A.,, D. J. Filman,, R. S. Fujinami,, J. P. Icenogle,, and J. M. Hogle. 1992. Three-dimensional structure of Theiler's virus. Proc. Natl. Acad. Sci. USA 89: 2061 2065.
19. Hahn, H.,, and A. C. Palmenberg. 1996. Mutational analysis of the encephalomyocarditis virus primary cleavage. J. Virol. 70: 6870 6875.
20. Hertzier, S.,, M. Luo,, and H. L. Lipton. 2000. Mutation of predicted virion pit residues alters binding of Theiler's murine encephalomyelitis virus to BHK-21 cells. J. Virol. 74: 19942004..
21. Hoffman, L. M.,, B. T. Fife,, W. S. Begolka,, S. D. Miller,, and W. J. Karpus. 1999. Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J. Neurovirol. 5: 635 642.
22. Jarousse, N.,, L. Fiette,, R. A. Grant,, J. M. Hogle,, A. McAllister,, T. Michiels,, C. Aubert,, F. Tangy,, M. Brahic,, and C. Pena Rossi. 1994. Chimeric Theiler's virus with altered tropism for the central nervous system. J. Virol. 68: 2781 2786.
23. Jarousse, N.,, R. A. Grant,, J. M. Hogle,, L. Zhang,, A. Senkowski,, R. P. Roos,, T. Michiels,, M. Brahic,, and A. McAllister. 1994. A single amino acid change determines persistence of a chimeric Theiler's virus. J. Virol. 68: 3364 3368.
24. Jarousse, N.,, C. Martinat,, S. Syan,, M. Brahic,, and A. McAllister. 1996. Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system. J. Virol. 70: 8213 8217.
25. Jelachich, M. L.,, and H. L. Lipton. 1996. Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis. J. Virol. 70: 6856 7861.
26. Jnaoui, K.,, and T. Michiels. 1999. Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains. J. Virol. 73: 7248 7254.
27. Kaminski, A.,, M. T. Howell,, and R. J. Jackson. 1990. Initiation of encephalomyocarditis virus RNA translation: the authentic initiation site is not selected by a scanning mechanism. EMBO J. 9: 3753 3759.
28. Kolupaeva, V. G.,, C. U. Hellen,, and I. N. Shatsky. 1996. Structural analysis of the interaction of the pyrimidine tract-binding protein with the internal ribosomal entry site of encephalomyocarditis virus and foot-and-mouth disease virus RNAs. RNA 2: 1199 1212.
29. Kong, W. P.,, and R. P. Roos. 1991. Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 65: 3395 3399.
30. Lehrich, J. R.,, B. G. Arnason,, and F. H. Hochberg. 1976. Demyelinative myelopathy in mice induced by the DA virus. J. Neurolog. Sci. 29: 149 160.
31. Liang, Z.,, A. Senkowski,, B. Shim,, and R. P. Roos. 1993. Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J. Virol. 67: 4404 4408.
32. Lin, X.,, L. R. Pease,, P. D. Murray,, and M. Rodriguez. 1998. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity. J. Immunol. 160: 5661 5668.
33. Lin, X.,, R. P. Roos,, L. R. Pease,, P. Wettstein,, and M. Rodriguez. 1999. A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity. J. Immunol. 162: 17 24.
34. Lin, X.,, N. R. Thiemann,, L. R. Pease,, and M. Rodriguez. 1995. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214: 91 99.
35. Lipton, H. L. 1975. Theiler's infection in mice: an unusual biphasic disease process leading to demyelination. Infect. lmmun. 11: 1147 1155.
36. Lipton, H. L.,, and M. L. Jelachich. 1997. Molecular pathogenesis of Theiler's murine encephalomyelitis virus-induced demyelinating disease in mice. Intervirology 40: 143 152.
37. Lipton, H. L.,, G. Twaddle,, and M. L. Jelachich. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69: 2525 2533.
38. Lloyd, R. E.,, M. J. Grubman,, and E. Ehrenfeld. 1988. Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J. Virol. 62: 4216 4223.
39. Lobert, P. E.,, N. Escriou,, J. Ruelle,, and T. Michiels. 1999. A coding RNA sequence acts as a replication signal in cardioviruses. Proc. Natl. Acad. Sci. USA 96: 11560 11565.
40. Luo, M.,, C. He,, K. S. Toth,, C. X. Zhang,, and H. L. Lipton. 1992. Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc. Natl. Acad. Sci. USA 89: 2409 2413.
41. Luo, M.,, K. S. Toth,, L. Zhou,, A. Pritchard,, and H. L. Lipton. 1996. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology 220: 246 250.
42. Miller, S. D.,, C. L. Vanderlugt,, W. S. Begolka,, W. Pao,, R. L. Yauch,, K. L. Neville,, Y. Katz-Levy,, A. Carrizosa,, and B. S. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3: 1133 1136.
43. Murray, P. D.,, K. Krivacic,, A. Chernosky,, T. Wei,, R. M. Ransohoff,, and M. Rodriguez. 2000. Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis. J. Neurovirol. 6( Suppl. 1): S44 S52.
44. Murray, P. D.,, D. B. McGavern,, X. Lin,, M. K. Njenga,, J. Leibowitz,, L. R. Pease,, and M. Rodriguez. 1998. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18: 7306 7314·
45. Murray, P. D.,, K. D. Pavelko,, J. Leibowitz,, X. Lin,, and M. Rodriguez. 1998. CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 72: 7320 7329.
46. Nitayaphan, S.,, M. M. Toth,, and R. P. Roos. 1985. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J. Virol. 53: 651 657.
47. Njenga, M. K.,, K. D. Pavelko,, J. Baisch,, X. Lin,, C. David,, J. Leibowitz,, and M. Rodriguez. 1996. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70: 1729 1737.
48. Ohara, Y.,, and R. Roos. 1987. The antibody response in Theiler's virus infection: new perspectives on multiple sclerosis. Prog. Med. Virol. 34: 156 179.
49. Ohara, Y.,, A. Senkowski,, J. L. Fu,, L. Klaman,, J. Goodall,, M. Toth,, and R. P. Roos. 1988. Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J. Virol. 62: 3527 3529.
50. Ohara, Y.,, S. Stein,, J. L. Fu,, L. Stillman,, L. Klaman,, and R. P. Roos. 1988. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 164: 245 255.
51. Pevear, D. C.,, J. Borkowski,, M. Calenoff,, E. Rozhon,, and H. L. Lipton. 1987. Analysis of the complete nucleotide sequence of the picomavirus Theiler's murine encephalomyelitis virus (TMEV) indicates that it is closely related to the cardioviruses. J. Virol. 61: 1507 1516.
52. Pilipenko, E. V.,, A. P. Gmyl,, S. V. Maslova,, G. A. Belov,, A. N. Sinyakov,, M. Huang,, T. D. Brown,, and V. I. Agol. 1994. Starting window, a distinct element in the cap-independent internal initiation of translation on picornaviral RNA. J. Molec. Biol. 241: 398 414.
52.a. Pilipenko, E. V.,, E. G. Viktorova,, S. T. Guest,, V. I. Agol,, and R. P. Roos. 2001. Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J. 20: 6899 6908.
53. Polydorides, A. D.,, H. J. Okano,, Y. Y. Yang,, G. Stefani,, and R. B. Darnell. 2000. A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing. Proc. Natl. Acad. Sci. USA 97: 6350 6355.
54. Pritchard, A. E.,, K. Jensen,, and H. L. Lipton. 1993. Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence. J. Virol. 67: 3901 3907.
54.a. Ransohoff, R. M.,, T. Wei,, K. D. Pavelko,, J.-C. Lee,, P. D. Murray,, and M. Rodriguez. 2002. Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4 + and CD8 + T cells and viral persistence. J. Virol. 76: 2217 2224.
55. Rodriguez, M.,, K. Pavelko,, and R. L. Coffman. 1995. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69: 7286 7290.
55.a. Rodriguez, M.,, R. P. Roos,, D. McGavern,, L. Zoecklein,, K. Pavelko,, H. Sang,, and X. Lin. 2000. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations. Virology 275: 9 19.
56. Roos, R. P.,, W. P. Kong,, and B. L. Semler. 1989. Polyprotein processing of Theiler's murine encephalomyelitis virus. J. Virol. 63: 5344 5353.
57. Roos, R. P.,, S. Stein,, M. Routbort,, A. Senkowski,, T. Bodwell,, and R. Wollmann. 1989. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J. Virol. 63: 4469 4473.
58. Sangar, D. V.,, S. E. Newton,, D. J. Rowlands,, and B. E. Clarke. 1987. All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res. 15: 3305 3315.
59. Sato, S.,, S. L. Reiner,, M. A. Jensen,, and R. P. Roos. 1997. Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection. J. Neuroimmunol. 76: 213 223.
60. Sato, S.,, L. Zhang,, J. Kim,, J. Jakob,, R. A. Grant,, R. Wollmann,, and R. P. Roos. 1996. A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype. Virology 226: 327 337.
61. Takata, H.,, M. Obuchi,, J. Yamamoto,, T. Odagiri,, R. P. Roos,, H. Iizuka,, and Y. Ohara. 1998. L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J. Virol. 72: 4950 4955.
62.Tangy, E, A. McAllister, and M. Brahic. 1991. Determinants of persistence and demyelination of DA strain of Theiler's virus are found only in VP1 gene. J. Virol. 63: 11011106.
63. Tesar, M.,, S. A. Harmon,, D. F. Summers,, and E. Ehrenfeld. 1992. Hepatitis A virus polyprotein synthesis initiates from two alternative AUG codons. Virology 186: 609 618.
64. Tsunoda, I.,, C. I. Kurtz,, and R. S. Fujinami. 1997. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology 228: 388 393.
65. Vanderlugt, C. L.,, W. S. Begolka,, K. L. Neville,, Y. Katz-Levy,, L. M. Howard,, T. N. Eagar,, J. A. Bluestone,, and S. D. Miller. 1998. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol. Rev. 164: 63 72.
66. Yamasaki, K.,, C. C. Weihl,, and R. P. Roos. 1999. Alternative translation initiation of Theiler's murine encephalomyelitis virus. J. Virol. 73: 8519 8526.
67. Yauch, R. L.,, J. P. Palma,, H. Yahikozawa,, C. S. Koh,, and B. S. Kim. 1998. Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J. Virol. 72: 6169 6174.
68. Zhou, L.,, X. Lin,, T. J. Green,, H. L. Lipton,, and M. Luo. 1997. Role of sialyloligosaccharide binding in Theiler's virus persistence. J. Virol. 71: 9701 9712.
69. Zhou, L.,, Y. Luo,, Y. Wu,, J. Tsao,, and M. Luo. 2000. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J. Virol. 74: 1477 1485.
70. Zurbriggen, A.,, C. Thomas,, M. Yamada,, R. P. Roos,, and R. S. Fujinami. 1991. Direct evidence for amino acid 101 of VP1 for central nervous system disease in Theiler's murine encephalomyelitis virus infection. J. Virol. 65: 1929 1937.

Tables

Generic image for table
TABLE 1

Phenotypic differences between TMEV subgroups

Citation: Roos R. 2002. Pathogenesis of Theiler's Murine Encephalomyelitis Virus-Induced Disease, p 427-435. In Semler B, Wimmer E (ed), Molecular Biology of Picornavirus. ASM Press, Washington, DC. doi: 10.1128/9781555817916.ch34
Generic image for table
TABLE 2

The cytolytic response, L*, and susceptibility

Citation: Roos R. 2002. Pathogenesis of Theiler's Murine Encephalomyelitis Virus-Induced Disease, p 427-435. In Semler B, Wimmer E (ed), Molecular Biology of Picornavirus. ASM Press, Washington, DC. doi: 10.1128/9781555817916.ch34

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error